Skip to main content
. Author manuscript; available in PMC: 2015 Nov 4.
Published in final edited form as: Am J Obstet Gynecol. 2015 Apr 30;213(5):729.e1–729.e9. doi: 10.1016/j.ajog.2015.04.032

Table 1.

Study patient characteristics in the TrimoSan© gel and no TrimoSan© gel groups.

TrimoSan© (n (%) or mean ± standard deviation* or median (variance)**) n=92 No TrimoSan© (n (%) or mean ± standard deviation*or median (variance)**) n=92 Total Patients n=184
Age (years)* 58 ± 15 60 ± 17 59 ± 16
Body Mass Index (kg/m2)* 29 ± 7.6 28 ± 7.4 28 ± 7.5
Race
Caucasian 56 (61) 48 (52) 105 (57)
African American 6 (7) 13 (14) 19 (10)
Hispanic 23 (25) 20 (22) 43 (23)
Asian 1 (1) 3 (3) 4 (2)
Other 5 (5) 8 (9) 13 (7)
Parity** 3 (2.6)
Vaginal deliveries** 2 (2.4)
Indication for pessary use
Prolapse 41 (44) 45 (49) 86 (47)
Urinary incontinence 35 (38) 30 (33) 65 (35)
Both prolapse and urinary incontinence 13 (14) 10 (11) 23 (13)
Smoking
Current 8 (9) 6 (7) 14 (8)
Past 26 (28) 28 (30) 54 (29)
Charleston Comorbidity Index* 0.77 ± 1.1 0.89 ± 1.8 0.82 ± 1.5
Insurance type
Private 36 (39) 38 (41) 74 (40)
Public 27 (29) 34 (37) 61 (33)
None 7 (8) 6 (7) 13 (7)
Education Level
Graduate 25 (27) 28 (30) 53 (29)
College 37 (40) 29 (32) 66 (36)
High school 20 (22) 28 (30) 48 (26)
Less than high school diploma 3 (3) 4 (4) 7 (4)
Job Activity Level
Sedentary work 16 (17) 16 (17) 32 (17)
Homemaker 18 (20) 18 (20) 36 (20)
Light labor 20 (22) 26 (28) 46 (25)
Heavy labor 8 (9) 5 (5) 13 (7)
Unemployed or retired 26 (28) 19 (21) 45 (24)
Prior pelvic surgery 41 (49) 39 (42) 80 (43)
Prior pessary use 9 (10) 4 (4) 13 (7)
Vaginal Infection History
Vaginal infection last 12 months 10 (11) 7 (8) 17 (9)
HT
Using hormone therapy (HT) at time of recruitment 22 (24) 24 (26) 46 (25)
Vaginal HT at time of recruitment 19 (21) 19 (21) 38 (21)
HT prescribed at time of recruitment 13 (14) 14 (15) 27 (15)
Pessary Refitting
Required refitting at 2 weeks 13 (14) 12 (13) 25 (14)
Required refitting at 3 months 15 (16) 12 (13) 27 (15)
BV Measures
BV by Nugent's criteria at baseline 23 (25) 15 (16) 38 (21)
Total Nugent's score at baseline* 4.5 ± 2.0 4.8 ± 2.4 4.6 ± 2.2
BV by BV® BLUE at baseline 1 (1) 2 (2) 3 (2)